Diabetes Mellitus, Type 1: Multimedia

References

1. Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child. Dec 2004;89(12):1138-44. [Medline]. [Full Text].

2. Barrett TG. Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered?. Pediatr Diabetes. Oct 2007;8 Suppl 6:15-23. [Medline].

3. Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM. Incidence of diabetes in youth in the United States. JAMA. Jun 27 2007;297(24):2716-24. [Medline].

4. Silink M. Childhood diabetes: a global perspective. Horm Res. 2002;57 Suppl 1:1-5. [Medline].

5. Soltesz G, Patterson CC, Dahlquist G. Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology?. Pediatr Diabetes. Oct 2007;8 Suppl 6:6-14. [Medline].

6. [Best Evidence] Dahlquist G, Kallen B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care. Oct 2005;28(10):2384-7. [Medline].

7. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. Oct 1999;81(4):318-23. [Medline]. [Full Text].

8. Koltin D, Daneman D. Dead-in-bed syndrome - a diabetes nightmare. Pediatr Diabetes. Oct 2008;9(5):504-7. [Medline].

9. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. Sep 30 1993;329(14):977-86. [Medline].

10. Gallego PH, Wiltshire E, Donaghue KC. Identifying children at particular risk of long-term diabetes complications. Pediatr Diabetes. Oct 2007;8 Suppl 6:40-8. [Medline].

11. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. Apr 29 2004;350(18):1838-49. [Medline].

12. Felner EI, Klitz W, Ham M, Lazaro AM, Stastny P, Dupont B. Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes. Dec 2005;6(4):213-20. [Medline].

13. Patterson CC, Carson DJ, Hadden DR. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia. Sep 1996;39(9):1063-9. [Medline].

14. Hyoty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. Jun 1995;44(6):652-7. [Medline].

15. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. Aug 2008;51(8):1391-8. [Medline].

16. [Best Evidence] International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. Jun 5 2009;[Medline].

17. Clar C, Waugh N, Thomas S. Routine hospital admission versus out-patient or home care in children at diagnosisof type 1 diabetes mellitus. Cochrane Database Syst Rev. 2003;CD004099. [Medline].

18. Delamater AM. Psychological care of children and adolescents with diabetes. Pediatr Diabetes. Oct 2007;8(5):340-8. [Medline].

19. Aslander-van Vliet E, Smart C, Waldron S. Nutritional management in childhood and adolescent diabetes. Pediatr Diabetes. Oct 2007;8(5):323-39. [Medline].

20. Robertson K, Adolfsson P, Riddell MC, Scheiner G, Hanas R. Exercise in children and adolescents with diabetes. Pediatr Diabetes. Feb 2008;9(1):65-77. [Medline].

21. Danne T, Deiss D, Hopfenmuller W, et al. Experience with insulin analogues in children. Horm Res. 2002;57 Suppl 1:46-53. [Medline].

22. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients withdiabetes mellitus. Cochrane Database Syst Rev. 2004;CD003287. [Medline].

23. US Food and Drug Administration. Early Communication About Safety of Lantus (insulin Glargine). Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169722.htm. Accessed July 1, 2009.

24. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type1 diabetes. J Pediatr. Dec 2003;143(6):796-801. [Medline].

25. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes [published erratum appears in Diabetes Care 1997 Jul;20(7):1216]. Diabetes Care. May 1997;20(5):714-20. [Medline].

26. Danne T, Mortensen HB, Hougaard P, et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemiain a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care. Aug 2001;24(8):1342-7. [Medline]. [Full Text].

27. Kaufman FR, Halvorson M, Carpenter S. Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic. Pediatrics. May 1999;103(5 Pt 1):948-51. [Medline]. [Full Text].

28. Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the AmericanDiabetes Association. Diabetes Care. Jan 2005;28(1):186-212. [Medline]. [Full Text].

29. Pihoker C, Forsander G, Wolfsdorf J, Klingensmith GJ. The delivery of ambulatory diabetes care: structures, processes, and outcomes of ambulatory diabetes care. Pediatr Diabetes. Dec 2008;9(6):609-20. [Medline].

30. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. Apr 2008;9(2):165-74. [Medline].

31. Hershey T, Perantie DC, Warren SL, et al. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care. Oct 2005;28(10):2372-7. [Medline]. [Full Text].

32. d'Annunzio G, Malvezzi F, Vitali L, Barone C, Giacchero R, Klersy C, et al. A 3-19-year follow-up study on diabetic retinopathy in patients diagnosed in childhood and treated with conventional therapy. Diabet Med. Nov 1997;14(11):951-8. [Medline].

33. Jones CA, Leese GP, Kerr S, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child. Jun 1998;78(6):518-23. [Medline]. [Full Text].

34. Barkai L, Madacsy L. Cardiovascular autonomic dysfunction in diabetes mellitus. Arch Dis Child. Dec 1995;73(6):515-8. [Medline].

35. Mohn A, Di Michele S, Di Luzio R, et al. The effect of subclinical hypothyroidism on metabolic control in children andadolescents with Type 1 diabetes mellitus. Diabet Med. Jan 2002;19(1):70-3. [Medline].

36. Barera G, Bonfanti R, Viscardi M, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospectivelongitudinal study. Pediatrics. May 2002;109(5):833-8. [Medline]. [Full Text].

37. Infante JR, Rosenbloom AL, Silverstein JH, et al. Changes in frequency and severity of limited joint mobility in children withtype 1 diabetes mellitus between 1976-78 and 1998. J Pediatr. Jan 2001;138(1):33-7. [Medline].

38. DiLiberti JH, Lorenz RA. Long-term trends in childhood diabetes mortality: 1968-1998. Diabetes Care. Aug 2001;24(8):1348-52. [Medline].

39. CDC. National Diabetes Fact Sheet. United States. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2003.pdf.

Further Reading

Keywords

diabetes mellitus type 1, insulin-dependent diabetes, IDM, insulin-dependent diabetes mellitus, IDDM, growth-onset diabetes, type I diabetes, type 1 diabetes, DM, diabetes, type 1 DM, T1DM, childhood diabetes, childhood diabetes mellitus, childhood-onset diabetes, childhood-onset diabetes mellitus, diabetes in childhood, diabetes mellitus in childhood, juvenile-onset diabetes, juvenile-onset diabetes mellitus, ketosis-prone diabetes, autoimmune diabetes mellitus, brittle diabetes mellitus, diabetic ketoacidosis, DKA, maturity-onset diabetes of the young, MODY, chamber-pot dropsy, thirst disease, sugar disease, sugar sickness

Contributor Information and Disclosures

Author

William H Lamb, MBBS, MD, FRCP(Edin), FRCP, Clinical Lecturer, Department of Child Health, The General Hospital, Bishop Auckland, UK
William H Lamb, MBBS, MD, FRCP(Edin), FRCP is a member of the following medical societies: British Medical Association, Royal College of Paediatrics and Child Health, and Royal College of Physicians
Disclosure: Medtronic UK Honoraria Speaking and teaching

Medical Editor

Arlan L Rosenbloom, MD, Adjunct Distinguished Service Professor Emeritus of Pediatrics, University of Florida; Fellow of the American Academy of Pediatrics; Fellow of the American College of Epidemiology
Arlan L Rosenbloom, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Epidemiology, American Pediatric Society, Endocrine Society, Florida Pediatric Society, Lawson-Wilkins Pediatric Endocrine Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London), Professor and Chair, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Greece
George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London) is a member of the following medical societies: American Academy of Pediatrics, American College of Endocrinology, American College of Physicians, American Pediatric Society, American Society for Clinical Investigation, Association of American Physicians, Endocrine Society, Lawson-Wilkins Pediatric Endocrine Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Merrily P M Poth, MD, Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences
Merrily P M Poth, MD is a member of the following medical societies: American Academy of Pediatrics, Endocrine Society, and Lawson-Wilkins Pediatric Endocrine Society
Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD, Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas and Arkansas Children's Hospital
Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research
Disclosure: Genentech, Inc. Honoraria Speaking and teaching; Pfizer, Inc. Honoraria Consulting